City

Grenoble (1)

Oakland (1)

Condition

Blepharospasm, Benign Essential (2)

Blepharospasm (1)

CBD (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

n/a (1)

phase 2/phase 3 (1)

Sponsor

Silkiss Eye Surgery (1)

University Hospital, Grenoble (1)

Collaborator

Benign Essential Blepharospasm Research Foundation (1)

Jazz Pharmaceuticals (1)

Smith-Kettlewell Eye Research Institute (1)

Intervention

cannabidiol oral solution [epidiolex] (1)

fmri (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Other (2)

Study Type

Interventional (2)

blepharospasm, benign essential

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Blepharospasm, Benign Essential Trial in Grenoble (fMRI)

Recruiting

Blepharospasm, Benign Essential

fMRI

Grenoble, France

CHU Grenoble Alpes

Feb 3, 2022

Blepharospasm, Blepharospasm, Benign Essential, CBD Trial in Oakland (Cannabidiol Oral Solution [Epidiolex])

Completed

Blepharospasm
+2 more

Cannabidiol Oral Solution [Epidiolex]

Oakland, California

Silkiss Eye Surgery

Oct 29, 2021